CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Tenofovir disoproxil fumarate

Last Updated: July 7, 2008
Result type: Reports
Project Number: SF0139-000
Product Line: Reimbursement Review

Generic Name: Tenofovir disoproxil fumarate

Brand Name: Viread

Manufacturer: Gilead Sciences Canada Inc.

Therapeutic Area: HIV infection

Indications: HIV infection

Submission Type: Request For Advice

Project Status: Complete